Old dogma, new tricks--21st Century phage therapy

|January 6, 2004

Abstract:

As antibiotic resistant bacteria threaten a public health crisis, biotechnology is turning to bacteriophages, nature's tiniest viruses. But can phage therapy overcome its historical baggage?

Related Experiment Videos

Old dogma, new tricks--21st Century phage therapy

Related Concept Videos

White blood cell count nadir following remission induction chemotherapy is predictive of outcome in older adults with acute myeloid leukemia.

Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells.

Characterization of microbial dark matter at scale with MetaSBT and taxonomy-aware Sequence Bloom Trees.

Proteome-wide identification of the druggable CRBN interactome.

Discovery and design of potent cell surface display elements.

Mechanistic machine learning for prediction of prime editing outcomes.

Simultaneous single-cell profiling of chromatin, transcriptome and surface markers with OneCell CUT&Tag captures epigenomic reprogramming.

Flexible Membrane-Integrated Zipper CHA Amplification for Rapid and Sensitive MicroRNA Detection.

Logic-Gated Dual-Aptamer Proximity AlphaLISA for Rapid and Sensitive Detection of Tumor-Derived Small Extracellular Vesicles.

Self-Cleaning Electrochemical Biosensor Based on MCOF@Ag for Simultaneous Pathogen Detection and Photocatalytic Inactivation.

Related Experiment Videos

Old dogma, new tricks--21st Century phage therapy

Abstract:

Related Concept Videos

Related Articles